Teacher Retirement System of Texas raised its position in Colgate-Palmolive (NYSE:CL) by 59.8% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 725,180 shares of the company’s stock after acquiring an additional 271,475 shares during the period. Teacher Retirement System of Texas owned about 0.08% of Colgate-Palmolive worth $51,981,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Santa Barbara Asset Management LLC lifted its stake in Colgate-Palmolive by 1.3% in the 3rd quarter. Santa Barbara Asset Management LLC now owns 1,719,532 shares of the company’s stock valued at $125,268,000 after acquiring an additional 22,745 shares in the last quarter. AMP Capital Investors Ltd lifted its stake in Colgate-Palmolive by 0.6% in the 3rd quarter. AMP Capital Investors Ltd now owns 594,665 shares of the company’s stock valued at $43,319,000 after acquiring an additional 3,680 shares in the last quarter. Asset Management One Co. Ltd. lifted its stake in Colgate-Palmolive by 1.8% in the 3rd quarter. Asset Management One Co. Ltd. now owns 1,388,544 shares of the company’s stock valued at $101,176,000 after acquiring an additional 24,216 shares in the last quarter. Segall Bryant & Hamill LLC increased its position in shares of Colgate-Palmolive by 12.9% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 16,336 shares of the company’s stock worth $1,190,000 after purchasing an additional 1,862 shares during the last quarter. Finally, Prospector Partners LLC increased its position in shares of Colgate-Palmolive by 82.7% during the 3rd quarter. Prospector Partners LLC now owns 138,250 shares of the company’s stock worth $10,072,000 after purchasing an additional 62,600 shares during the last quarter. Hedge funds and other institutional investors own 74.26% of the company’s stock.
Several research analysts have weighed in on the company. Barclays set a $70.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Monday, April 30th. ValuEngine lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Citigroup lowered their price target on Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 1st. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, April 18th. Finally, Morgan Stanley lowered Colgate-Palmolive from an “overweight” rating to an “equal weight” rating in a research report on Monday, April 30th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $76.75.
In related news, insider Daniel B. Marsili sold 19,500 shares of the business’s stock in a transaction that occurred on Monday, April 16th. The stock was sold at an average price of $71.85, for a total transaction of $1,401,075.00. Following the transaction, the insider now directly owns 77,935 shares of the company’s stock, valued at approximately $5,599,629.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Franck J. Moison sold 80,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total value of $4,940,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 184,142 shares of company stock worth $11,933,716 over the last three months. 1.02% of the stock is owned by insiders.
Colgate-Palmolive opened at $62.13 on Friday, MarketBeat Ratings reports. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 64.85. The company has a market cap of $54.16 billion, a P/E ratio of 21.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75. Colgate-Palmolive has a 1-year low of $61.51 and a 1-year high of $62.40.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. The business had revenue of $4 billion for the quarter, compared to analyst estimates of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.67 EPS. equities analysts forecast that Colgate-Palmolive will post 3.17 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 15th. Investors of record on Friday, April 20th were issued a dividend of $0.42 per share. The ex-dividend date was Thursday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.70%. Colgate-Palmolive’s payout ratio is presently 58.54%.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.